MN is an immune-relevant kidney disease with various target antigens identified, including phospholipase A2 receptor, thrombospondin type 1 domain-containing 7 A, and neural epidermal growth factor-like 1 protein [33,34]. This evidence concerns the gene THSD7A and kidney disorder.